Cefdinir Powder, For Suspension
Product Images NDC 68788-8655

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 68788-8655). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Cedfinir Monohydrate (Image 1)

Chemical structure of Cefdinir showing its molecular framework with characteristic beta-lactam and dihydrothiazine rings, including functional groups and hydration as indicated by a water molecule (H2O).*

FDA Label Image

Cefdinir For Oral Suspension Usp 250mg5ml (Image 3)

Label for Cefdinir for Oral Suspension, USP 250 mg/5 mL powder for suspension, generic for Omnicef. Manufactured by Teva Pharmaceuticals USA Inc. Includes dosage instructions in English and Spanish on a bright yellow background, a barcode, and caution about drug transfer.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.